04:37 PM EDT, 06/14/2024 (MT Newswires) -- AbbVie ( ABBV ) late Friday recommended shareholders decline from participating in an unsolicited mini-tender offer from Tutanota seeking to buy up to 250,000 of the drug maker's shares at $165 apiece.

AbbVie ( ABBV ) said the May 28 tender offer is conditioned on its share price closing above the offer price on the final day of the tender period, adding Tutanota has indicated it may extend its purchase offer by up to 180 days until the stock tops that threshold.